Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 55 years or older who live in the community (not in a care facility) and had a stroke (either a blocked artery or a bleeding stroke) at least one year before joining the study
- People who have poor sleep quality, measured by a sleep efficiency of 85% or below and a score above 5 on a standard sleep quality questionnaire called the PSQI
- People with a reasonable level of memory and thinking ability, based on scores of 22 or above (out of 30) on the MMSE test and 19 or above (out of 30) on the MoCA test
- People who are able to attend scheduled appointments, classes, and other parts of the trial as required
- People who can read, write, and speak English, with adequate vision and hearing
- People who are either not taking any medications that affect sleep, or who have been on a stable, unchanged dose of such medications for at least 6 months and will remain on that dose throughout the 26-week study period
- People who can walk at least 6 metres, even with rest breaks and/or a walking aid
- People who, based on an interview, can be active for up to 60 minutes with rest breaks
- People who are not currently doing regular structured exercise or progressive training (such as treadmill workouts or weight lifting)
- People who are cleared to exercise safely based on a standard health screening questionnaire (PAR-Q+) and written confirmation from a family doctor or study physician
Who may not be able to join:
- People diagnosed with obstructive sleep apnea (OSA) who are not using a CPAP machine, or people whose study screening results suggest they may have undiagnosed OSA (with an AHI score above 20)
- People who have restless leg syndrome
- People who have been diagnosed with any form of dementia
- People who have been diagnosed with another neurological or neurodegenerative condition, such as Parkinson's disease
- People who are already enrolled in, or planning to join, another clinical drug trial or exercise trial at the same time as this study
- People considered at high risk for heart complications during exercise, or who are unable to self-regulate their activity level or understand recommended activity guidelines
- People whose doctor has identified significant nerve damage (peripheral neuropathy) or severe joint or muscle disease that affects their ability to move
- People who have aphasia (a communication difficulty after stroke) that makes it impossible to communicate by phone
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Teresa Liu-Ambrose, PhD, University of British Columbia
Phone: 604-617-8047
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sleep Efficiency
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.